← Back to headlines
EU Evaluates Pfizer Vaccine Candidate for Lyme Disease
The European Union has begun evaluating an experimental vaccine developed by Pfizer for the prevention of Lyme disease in children and adults, aiming to approve the first such vaccine against the tick-borne infection.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
